a multicenter double-blind randomized study was designed to evaluate and compare the safety and diagnostic efficacy of gadopentetate dimeglumine ( gd-dtpa ) ( 0.1 mmol/kg ) against a saline placebo for use as an iv contrast agent for mr .
C0060934
gadopentetate dimeglumine
C0060933
gd-dtpa